Н. Л. Миронова

1.1k total citations
55 papers, 889 citations indexed

About

Н. Л. Миронова is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Н. Л. Миронова has authored 55 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 19 papers in Immunology and 14 papers in Cancer Research. Recurrent topics in Н. Л. Миронова's work include RNA Interference and Gene Delivery (21 papers), Immunotherapy and Immune Responses (11 papers) and RNA and protein synthesis mechanisms (10 papers). Н. Л. Миронова is often cited by papers focused on RNA Interference and Gene Delivery (21 papers), Immunotherapy and Immune Responses (11 papers) and RNA and protein synthesis mechanisms (10 papers). Н. Л. Миронова collaborates with scholars based in Russia, United Kingdom and Chile. Н. Л. Миронова's co-authors include Marina A. Zenkova, Oleg V. Markov, Valentin V. Vlassov, Olga Patutina, Aleksandra V. Sen’kova, М. А. Маслов, Д. В. Пышный, Н. Г. Морозова, С. К. Мирошниченко and Н. А. Попова and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Biomaterials.

In The Last Decade

Н. Л. Миронова

55 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Н. Л. Миронова Russia 18 675 271 211 156 69 55 889
Zining Wang China 14 449 0.7× 408 1.5× 97 0.5× 185 1.2× 60 0.9× 36 814
Elena L. Chernolovskaya Russia 18 931 1.4× 163 0.6× 235 1.1× 74 0.5× 86 1.2× 78 1.1k
Valesca Bukur Germany 7 393 0.6× 247 0.9× 119 0.6× 182 1.2× 80 1.2× 15 678
Émilie Brotin France 18 529 0.8× 154 0.6× 281 1.3× 237 1.5× 31 0.4× 34 840
Ge Zhu China 14 388 0.6× 187 0.7× 114 0.5× 173 1.1× 34 0.5× 34 766
Pekka Rappu Finland 16 504 0.7× 64 0.2× 197 0.9× 100 0.6× 58 0.8× 30 785
Sihe Zhang China 16 636 0.9× 182 0.7× 158 0.7× 152 1.0× 42 0.6× 49 913
Elisabetta Bolli Italy 14 271 0.4× 235 0.9× 105 0.5× 200 1.3× 52 0.8× 28 574
Maria S. Iliou United States 9 477 0.7× 148 0.5× 149 0.7× 220 1.4× 75 1.1× 11 657
You Wang China 15 459 0.7× 119 0.4× 95 0.5× 118 0.8× 54 0.8× 53 702

Countries citing papers authored by Н. Л. Миронова

Since Specialization
Citations

This map shows the geographic impact of Н. Л. Миронова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Н. Л. Миронова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Н. Л. Миронова more than expected).

Fields of papers citing papers by Н. Л. Миронова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Н. Л. Миронова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Н. Л. Миронова. The network helps show where Н. Л. Миронова may publish in the future.

Co-authorship network of co-authors of Н. Л. Миронова

This figure shows the co-authorship network connecting the top 25 collaborators of Н. Л. Миронова. A scholar is included among the top collaborators of Н. Л. Миронова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Н. Л. Миронова. Н. Л. Миронова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sen’kova, Aleksandra V., et al.. (2024). Tumor- and Fibroblast-Derived Cell-Free DNAs Differently Affect the Progression of B16 Melanoma In Vitro and In Vivo. International Journal of Molecular Sciences. 25(10). 5304–5304. 3 indexed citations
3.
Sen’kova, Aleksandra V., et al.. (2024). Tbp and Hprt1 Are Appropriate Reference Genes for Splenic Neutrophils Isolated from Healthy or Tumor-Bearing Mice. Biomedicines. 12(11). 2571–2571. 1 indexed citations
4.
Markov, Oleg V., et al.. (2023). A Comparative Study of Different Protocols for Isolation of Murine Neutrophils from Bone Marrow and Spleen. International Journal of Molecular Sciences. 24(24). 17273–17273. 7 indexed citations
5.
Savin, Innokenty A., et al.. (2023). The Effect of Cell-Free DNA from Blood Serum of Mice with Metastatic Melanoma on Enhancement of Oncogenic Properties of Melanoma Cells. Biochemistry (Moscow). 88(7). 995–1007. 2 indexed citations
6.
Sen’kova, Aleksandra V., Oleg V. Markov, Andrey V. Markov, et al.. (2022). Bovine Pancreatic RNase A: An Insight into the Mechanism of Antitumor Activity In Vitro and In Vivo. Pharmaceutics. 14(6). 1173–1173. 1 indexed citations
7.
Markov, Oleg V., Aleksandra V. Sen’kova, Elena V. Shmendel, et al.. (2022). Dendritic Cell-Derived Artificial Microvesicles Inhibit RLS40 Lymphosarcoma Growth in Mice via Stimulation of Th1/Th17 Immune Response. Pharmaceutics. 14(11). 2542–2542. 3 indexed citations
9.
Kupryushkin, Maxim S., Н. Л. Миронова, Olga Patutina, et al.. (2021). Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells. Molecular Therapy — Nucleic Acids. 27. 211–226. 26 indexed citations
11.
Zelenikhin, Pavel, Vera Ulyanova, Н. Л. Миронова, et al.. (2020). Рибонуклеаза Bacillus pumilus ингибирует миграцию клеток аденокарциномы двенадцатиперстной кишки человека HuTu 80. Молекулярная биология. 54(1). 146–152. 6 indexed citations
12.
Markov, Oleg V., Н. Л. Миронова, Elena V. Shmendel, М. А. Маслов, & Marina A. Zenkova. (2017). Systemic delivery of complexes of melanoma RNA with mannosylated liposomes activates highly efficient murine melanoma-specific cytotoxic T cells in vivo. Molecular Biology. 51(1). 102–107. 9 indexed citations
14.
Markov, Oleg V., Н. Л. Миронова, С. В. Сенников, Valentin V. Vlassov, & Marina A. Zenkova. (2015). Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma. PLoS ONE. 10(9). e0136911–e0136911. 27 indexed citations
15.
Миронова, Н. Л., et al.. (2012). The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma. ISRN Oncology. 2012. 1–15. 7 indexed citations
16.
Markov, Oleg V., Н. Л. Миронова, М. А. Маслов, et al.. (2011). Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets. Journal of Controlled Release. 160(2). 200–210. 52 indexed citations
17.
Patutina, Olga, Н. Л. Миронова, Valentin V. Vlassov, & Marina A. Zenkova. (2009). New Approaches for Cancer Treatment: Antitumor Drugs Based on gene-Targeted Nucleic Acids. Acta Naturae. 1(2). 44–60. 7 indexed citations
18.
Миронова, Н. Л., et al.. (2007). RNase T1 mimicking artificial ribonuclease. Nucleic Acids Research. 35(7). 2356–2367. 31 indexed citations
19.
Миронова, Н. Л., et al.. (2006). Animal Model of Drug‐Resistant Tumor Progression. Annals of the New York Academy of Sciences. 1091(1). 490–500. 19 indexed citations
20.
Миронова, Н. Л., et al.. (2002). Artificial Ribonucleases: Oligonucleotide–Peptide Conjugates That Cleave RNA at the GpX and PypA Phosphodiester Bonds. Doklady Biochemistry and Biophysics. 385(1-6). 196–200. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026